Digitalisation has been mentioned as one of the main pillars within the Pharmaceutical Strategy for Europe, being considered a key tool to easy the regulatory burden, facilitate the communication between all the stakeholders, and address particular needs of the regulatory landscape. The two most highlighted examples are the use of electronic product information and the simplification of regulatory procedures through digital platforms.
Next congress sessions are scheduled on the 2nd and 4th of February.
At Asphalion we will stay tuned to keep you updated on all forthcoming changes!
If you have any questions do not hesitate to contact us at: firstname.lastname@example.org